New Treatment for Major Depressive Disorder in Adults Demonstrated Safe and Effective in Clinical Studies NEW YORK - Forest Laboratories, Inc. (NYSE: FRX) announced today that VIIBRYD(TM) (vilazodone HCl tablets) is now available at pharmacies throughout the United States. VIIBRYD is a prescription medicine indicated for the treatment of adults with major depressive disorder (MDD). The U.S. Food and Drug Administration (FDA) approved VIIBRYD as a new molecular entity on January 21, 2011, making it the first and only approved selective serotonin reuptake inhibitor (SSRI) and 5HT1A receptor partial agonist. The mechanism of the antidepressant effect of VIIBRYD is not fully understood but is...
↧